Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the jetpack-backup domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /home/vgbdoo6u2d7y/public_html/mcmillanresearch.com/wp-includes/functions.php on line 6121
Uncovering the Truth Behind Covid Autoimmune Response - McMillan Research Limited
Select Page
Exploring the impact of autoimmunity in different stages of Covid-19 progression.
  • Autoimmunity can turn the body’s protector into its persecutor. 3:18

  • Understanding the role of serum/plasma A2 in autoimmunity is crucial. 3:33

  • Autoimmunity to A2 and other proteins can have significant implications. 3:41

  • Different stages of Covid-19 progression include asymptomatic/mild cases, bronchitis, viral pneumonia, moderate Covid, and severe pneumonia. 4:15

  • Severe Covid cases may involve a combination of viral pneumonia and microclots. 5:09

Understanding the relationship between viruses and autoimmune diseases, specifically in the context of severe Covid-19.
  • Autoimmunity occurs when antibodies target the body’s own cells, leading to inflammation and damage. 5:57

  • Viral mediated autoimmune diseases are well-known, with various viruses linked to triggering autoimmune responses in diseases like multiple sclerosis and rheumatoid arthritis. 7:25

  • The hypothesis that Covid-19 is a viral mediated autoimmune disease was explored in early 2020 to improve treatment approaches and save lives. 9:00

  • Research focused on autoantibodies to ACE2, the entry receptor for the virus, to understand the autoimmune response to Covid-19. 9:52

  • Papers were published in 2020 and 2021 outlining the theory of autoimmunity to ACE2, highlighting the importance of understanding the autoimmune response in severe Covid-19 cases. 10:11

  • Challenges in research funding and publication delays were faced, but the importance of studying the autoimmune response in Covid-19 remained crucial for long-term health outcomes. 11:00

Insights on the atypical autoimmune response in Covid-19 and its impact on disease severity.
  • Auto antibodies to ace2 associated with severe Covid-1. 11:25

  • Presence of elevated IGG and IGA Auto antibodies in severe Covid-19 case. 12:38

  • Unusual characteristics of Covid-19 including varying symptoms and sex-based mortality rate difference. 14:05

  • Higher risk of hospitalization in elderly, racial disparities, and association with hypertension and obesit. 15:20

  • Clinical observations suggesting Covid-19’s unique mechanism compared to typical respiratory viruse. 16:22

Insights on autoimmune response in severe COVID-19 cases and potential risk factors.
  • Spike proteins on the virus play a crucial role in cell entry. 16:31

  • Differentiating viral pneumonia from moderate to severe COVID-19 is important. 17:52

  • Viral phase of the disease can be asymptomatic but still cause significant lung inflammation. 19:39

  • Elevated levels of free Ace 2 in the bloodstream may be linked to severe COVID-19 cases. 21:38

Understanding the autoimmune response in severe Covid-19 cases.
  • Inflammation of blood vessels leads to microclots in severe Covid-19. 21:55

  • Differentiating types of severe Covid-19 based on symptoms and progression. 22:20

  • Consistency in antibody response timing and presentation of severe disease. 23:39

  • Autoimmunity causing the body’s protector to become its persecutor. 24:41

  • Link provided for Co Advance 360 pre-launch sale. 24:58

  • Importance of joining the webinar for further discussion. 25:06